Our Pillars of Safety
At JB Pharma, we embrace and leverage the inherent strength of a diverse workforce across varying gender, caste, geographic origin, age, disability, socio-economic status, expertise, educational background, among others. Our workforce is at the fulcrum of accelerating innovation, growth and improved health outcomes. We nurture an inclusive culture built on trust and respect through myriad of Diversity, Inclusion and Equity (DE&I) initiatives to make it a part of our DNA.
Employee-Centric Approach
At the heart of our organizational philosophy lies a strong emphasis on our valued employees. We not
only prioritize their well-being but also champion gender diversity, uphold principles of equal pay, and
make strategic investments in human capital as integral components of our corporate ethos. By
fostering a diverse and inclusive workforce and investing in our employees’ development, we not only
create a vibrant and fulfilling workplace but also enhance our capacity for innovation and growth.
Workforce Breakdown by Gender
| Share of women in total workforce (as % of total workforce) | 10.36% |
|---|---|
| Share of women in all management positions | 9.31% |
| Share of women in junior management positions | 8.78% |
| Share of women in top management positions | 9.69% |
| Share of women in management positions in revenue-generating functions | 3.37% |
| Share of women in STEM-related positions in revenue-generating functions (as % of total STEM positions) | 21.13% |
Gender Pay Indicators
| Employee Level | Average Women Salary | Average Men Salary |
|---|---|---|
| Executive level (base salary only) | 0 | 0 |
| Executive level (base salary + other cash incentives) | 7,500,000 | 7,500,000 |
| Management level (base salary only) | 338,196 | 348,408 |
| Management level (base salary + other cash incentives) | 678,348 | 734,064 |
| Non-management level | 190,536 | 165,672 |
Recognizing the significance of fostering a culture of excellence, we place great importance on our performance appraisal processes, ensuring that exceptional performance is duly acknowledged and rewarded. This systematic approach to performance evaluation motivates our employees to continually excel ensuring that the alignment of individual achievements with organizational goals remains a top priority, driving our collective success.
100 % of our employees are given a performance appraisal by management by objectives (MBO) at least once yearly.
Human Capital Return on Investment
| FY 2020-21 | FY 2021-22 | FY 2022-23 | |
|---|---|---|---|
| Total Revenue (Currency: INR – Indian Rupee) | 189,199.55 | 218,897.63 | 288,416.41 |
| Total Operating Expenses (Currency: INR – Indian Rupee) | 110,419.72 | 135,813.54 | 186,582.62 |
| Total employee related expenses (salaries + benefits) (Currency: INR – Indian Rupee) | 30,597.97 | 39,906.20 | 49,994.59 |
| Total Employees | 4122 | 4340 | 5095 |
was the average amount spent per full time employee on training and
development in FY 23
New Hiring
The internal hiring percentage for the financial year 2021-22 was 2.17%, which
increased to 8.67% in the year 2022-23
| FY 2019-20 | FY 2020-21 | FY 2021-22 | FY 2022-23 | |
|---|---|---|---|---|
| Total number of new employee hires | 1361 | 609 | 1518 | 1615 |
At JB Pharma, we encourage and nurture all forms of Diversity. Our endeavours are focused to ensure equal representation of people from all facets of society. Our initiatives prove that diversity, equity and inclusion provide real grounds of creativity and efficiency and must remain at the centre of our actions.”
Mr. Sridhar Bharadwaj
(Vice President Human Resources)
To echo our commitment, we have curated a ‘Diversity, Equity and Inclusion’ (DE&I) framework which guides our everyday interactions for fostering collaboration and creativity that triggers new ideas, promote innovation and drive breakthrough performance. Our DE&I framework propels our diversity agenda and is underpinned the following defined objectives:
Access to Healthcare
Access to healthcare is a paramount goal within our organization, central to our commitment to sustainability. As a pharmaceutical company, we recognize the profound impact that access to quality healthcare has on individuals, families, and communities worldwide. We firmly believe that healthcare is a fundamental human right, and it is our duty to contribute to the realization of this right. We understand it is vital to bridge the gap between medical advancements and the individuals who require them the most. We collaborate with various healthcare organizations, non-profits, and governmental bodies dedicated to underserved communities. These partnerships allow us to identify and address the specific healthcare needs of vulnerable populations.
JB Pharma has approved an amount of 125 lakhs for the treatment of underprivileged children suffering from Growth Hormone Deficiency (GHD) at All India Institute of Medical Sciences (AIIMS), New Delhi, making a significant impact on their healthcare.
JB Pharma’s contribution of 50 lakhs to the Ankleshwar Industrial Development Society will facilitate the establishment of a Radiation Centre at Shreemati Jayaben Mody Hospital in Ankleshwar, Gujarat, benefiting impoverished cancer patients.
We have committed not to patent or enforce patents on all Intellectual Property related to all products for diseases in scope of ATMI 2021
JB Pharma has allocated 31 lakhs to the Parivaar Education Society for the educational upliftment and nutritional support of economically disadvantaged tribal children in Chhindwara district, Madhya Pradesh.
Shrimad Rajchandra Gurukul in South Gujarat will see a transformation in its educational capabilities, with JB Pharma’s approved donation of 37 lakhs, which will be utilized to provide electronic equipment for remedial education to students, both within the Gurukul and in outreach schools.
The Neonatal Intensive Care Unit at Shri Vinoba Bhave Civil Hospital in Silvasa, under the U.T. Administration of Dadra & Nagar Haveli and Daman & Diu, will receive 20 lakhs to acquire Fiber Optic Bronchoscope equipment, enhancing the healthcare services provided to newborns.
| Impact on Access to Healthcare | FY 20 | FY 21 | FY 22 |
|---|---|---|---|
| Number of patients with low-cost access to the organization’s products to address diseases | 59400000 | 75100000 | 156800000 |
| Number of patients for the organization’s products to address diseases | 92800000 | 114000000 | 156800000 |
Our marquee program Sneh Samwad
In line with our People First philosophy, this training program is designed and aimed at supporting women to enable learning, well-being, and safety. In FY 2022-23, we conducted 12 sessions with the participation of 272 women employees across function and locations.
Program focus areas
- Build a strong communication channel
- A consistent two-way communication
- Bring more transparency
- Emphasis on wellness and hygiene
- Building high motivation among all women employees
- Learning and inspiring from each other
- Building a collaborative culture of Respect, Trust and Valued.
- To encourage, enable and facilitate the active involvement of women employee in learning
JB Cares
In line with our People First philosophy, this training program is designed and aimed at supporting women to enable learning, well-being, and safety. In FY 2022-23, we conducted 12 sessions with the participation of 272 women employees across function and locations.
“I have gained valuable knowledge and received expert consultations, enabling me to prioritize my health and well-being. By focusing on my overall health goals, I have experienced increased energy levels, mindfulness, and a sense of accomplishment. After all, happiness and success start with good health.”
Mr. Pravin Deotarse
(Senior Manager)